AlphaGrep UK’s Core Scientific CORZ Stock Holding History

AlphaGrep UK’s Portfolio CORZ Stock Details CORZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-8,695	Closed	-$223K	–	788
2026 Q2	$223K	Buy	+8,695	New	+$205K	0.07%	644

Other funds holding CORZ

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.81B AUM 16.14% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

ORG Wealth Partners Dallas, Texas $607M AUM 23.88% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

AlphaGrep UK's CORZ Position: Q3 2026 in Review

AlphaGrep UK sold out of Core Scientific (CORZ) in Q3 2026, closing a stake of 8,695 shares — an estimated $223K sold.

AlphaGrep UK first reported a position in CORZ in Q2 2026 and held it in 1 quarter. The position peaked at $223K in Q2 2026. 288 funds tracked by Wall St. Rank hold CORZ as of Q3 2026.

AlphaGrep UK reported no remaining Core Scientific position as of Q3 2026 after selling out during the quarter.
AlphaGrep UK sold 8,695 Core Scientific shares in Q3 2026, an estimated $223K.
AlphaGrep UK first reported a position in Core Scientific in Q2 2026 and held it in 1 quarter.
AlphaGrep UK's Core Scientific position peaked at $223K in Q2 2026.
288 funds tracked by Wall St. Rank held Core Scientific as of Q3 2026.

Based on AlphaGrep UK's 13F filing for Q3 2026, filed 12 Nov 2026.